Brief: SkinBioTherapeutics Expects To Be Cash Flow Positive From FY2025
Nov 19 (Reuters) - SkinBioTherapeutics PLC SBTX.L :
* SKINBIOTHERAPEUTICS - FINALISATION OF COMMERCIAL
AGREEMENT WITH
CRODA
* SKINBIOTHERAPEUTICS PLC - EXPECTS TO BE CASH FLOW POSITIVE
FROM
FY2025
Source text: ID:nRSS7008Ma
Further company coverage: SBTX.L
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company